Marijuana - Up in Smoke - Industry related news & stock comments

Canopy sure squashed the market

They reported a decline in revenue, low gross margins and a massive net loss. Canopy subtracted $6.4 million from revenues because it expects cannabis oil and soft gel products to be returned unsold. Quarterly revenue fell to $90.5 million, down -4% from the previous quarter.

First of all, thanks Ron for some great Pot picks, all but one with triple digit gains. I agree the market looks too frothy

The Financial Post reports in its Friday, May 10, edition that many Canadian licensed producers may never achieve profitability and eventually lose ground to their American peers because of oversupply and onerous marketing restrictions. The Post's Vanmala Subramaniam writes that Medreleaf (now owned by Aurora Cannabis) former chief financial officer Igo Gimelshtein says: "There are 150 companies, millions of square feet of greenhouse space presumably coming online in the next three to five years, and just 35 million people. This is going to turn into the microbrewery business where no one makes any money." Mr. Gimelshtein says he was eager to sell Medreleaf last year because he believes an oversupply situation will be forthcoming in the next few years. He says: "We thought the situation in Canada was getting ridiculous, the valuations were crazy. If you could brand your products the way you can in the U.S. it could create strong pricing and differentiated margins, but you can't do that here."

To start the topic, the Pot market could be on the verge of it's first major consolidation as the Canadian market approached 50% penetration on the 'S' curve. ETF HMMJ looks like a head and shoulders top formation has occured